20 Nov 2018 | 6:45 AM
 

Strides Pharma Science Ltd. Share Price Live (BSE)
0

BSE Code: 532531 | NSE Symbol: STAR
461.10
-3.35
(-0.72 %)
19 Nov 2018 | 03:49 PM
Change company
  • Open (Rs)
    466.80
  • Prev. close (Rs.)
    464.45
  • High (Rs.)
    471.35
  • Low (Rs.)
    454.00
  • 52W H (Rs.)
    855.20
  • 52W L (Rs.)
    334.10
  • Volume
    107895
  • MCap (Rs in Cr.)
    4,129.11
463.5
-2.60
(-0.56 %)
  • Open (Rs)
    467.10
  • High (Rs)
    471.50
  • Low (Rs)
    453.05
  • Prev. close(Rs)
    466.10
  • Contracts Tra.
    17,00,800
  • Turnover (Cr.)
    79
  • Open Interest
    33,19,200
  • Open Int. chg
    -2,90,400.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
73.80
Operating Margin (%)
13.96
Gross Profit Margin (%)
8.54
Net Profit Margin (%)
23.26
Total Debt/Equity
1.02
Dividend payout Ratio (Net Profit)
7.38
Earning Retention Ratio
62.64

News

09 Nov 2018 - 12:28:00-Strides Pharma Science Friday said its step-down subsidiary has entered into an exclusive product de...
31 Oct 2018 - 15:54:00-Drug firm Strides Pharma Science Wednesday said it has partnered with funds advised by ICP-III Inves...
18 Sep 2018 - 16:31:00-Drug firm Strides Pharma Science Tuesday said the US health regulator has issued three observations ...
07 Sep 2018 - 00:11:00-Strides Pharma Science`s promoter Abusha Investment & Management Services LLP sold 4 lakh shares of ...

Announcements

09-Nov-2018
Strides teams up with SUDA Pharma for US market
09-Nov-2018
Strides Pharma Scien - Announcement under Regulation 30 (LODR)-Press Release / Media Release
09-Nov-2018
Strides Pharma Scien - Press Release
31-Oct-2018
Strides Pharma Scien - Announcement under Regulation 30 (LODR)-Press Release / Media Release
31-Oct-2018
Strides Pharma Scien - Press Release

Religare Research

19 Nov 2018 | 11:32 AM
Highlights : • Moderate weakness was shown for most Agri counters as profit booking set in for the ...
19 Nov 2018 | 10:35 AM
DTF
19 Nov 2018 | 10:14 AM
The rupee settled at 71.92 to a dollar, its highest since Sep. 14, against 71.98 at previous close. ...
19 Nov 2018 | 07:00 AM
We maintain our cautious view on markets and suggest booking profit on every rise, citing major hurd...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
16,99,963 148.36 172.97 -0.14
16,99,963 148.36 60.22 -0.14
16,99,963 148.36 1,039.03 -0.14
16,99,963 148.36 546.89 -0.14
16,99,963 148.36 1,083.10 -0.14

Shareholding Pattern

       
Promotors30.79%
Mutual Funds/UTI24.39%
FI/Banks1.09%
Insurance1.09%
FII22.05%
Government0.00%
Others7.58%

Peer Group

Company Intraday Graph
 Merck Ltd.
2,961.80(-2.17)
3302
 AstraZeneca Pharma India Ltd.
1,647.60(-0.70)
3274
 Dr. Lal Pathlabs Ltd.
837.75(0.13)
17140
 Ipca Laboratories Ltd.
763.00(0.65)
3488

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Strides Pharma Science Ltd.36.759.70120.10
NIFTY(S&P CNX)459.85-788.35246.70
BSE SENSEX1,459.25-2,503.871,158.75
BSE 500641.32-1,259.84-103.06

Corporate Details

Key Personal
Abhaya Kumar
Executive Director
Arun Kumar
Chairman
Arun Kumar
Exec. Vice Chairman & Mang Dir
Key Address
Registered Office
201 Devavrata Sector 17 Vashi,New Mumbai,Maharashtra

Tel:022-27893199, Fax:022-27892942

info@strides.com
http://www.strides.com
Registrar Office
In House